Atomoxetine hydrochloride
Atomoxetine hydrochloride is a pharmaceutical drug with 32 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 31 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
28
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
31 of 31 finished
0.0%
0 ended early
1
trials recruiting
32
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
Study of Atomoxetine in the Prevention of Vasovagal Syncope
Atomoxetine PBPK-PD Clinical Study
Parallel Arm Trial of AD109 and AD504 In Patients With OSA
Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical Trials (32)
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
Study of Atomoxetine in the Prevention of Vasovagal Syncope
Atomoxetine PBPK-PD Clinical Study
Parallel Arm Trial of AD109 and AD504 In Patients With OSA
Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD
ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD
A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)
Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes
Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)
Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD
Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)
Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 32